IFN-γ activated JAK1 shifts CD40-induced cytokine profiles in human antigen-presenting cells toward high IL-12p70 and low IL-10 productionCONZELMANN, Michael; WAGNER, Andreas H; HECKER, Markus et al.Biochemical pharmacology. 2010, Vol 80, Num 12, pp 2074-2086, issn 0006-2952, 13 p.Conference Paper

The CD6 Scavenger Receptor Is Differentially Expressed on a CD56^dim Natural Killer Cell Subpopulation and Contributes to Natural Killer-Derived Cytokine and Chemokine SecretionBRAUN, Monika; MÜLLER, Bernadette; LERCHL, Tina et al.Journal of innate immunity (Print). 2011, Vol 3, Num 4, pp 420-434, issn 1662-811X, 15 p.Article

Natural killer resistance of a drug-resistant leukemia cell line, mediated by up-regulation of HLA class I expressionCLASSEN, Carl Friedrich; FALK, Christine S; FRIESEN, Claudia et al.Haematologica (Roma). 2003, Vol 88, Num 5, pp 509-521, issn 0390-6078, 13 p.Article

NK-cell education is shaped by donor HLA genotype after unrelated allogeneic hematopoietic stem cell transplantationHAAS, Philippe; LOISEAU, Pascale; TOUBERT, Antoine et al.Blood. 2011, Vol 117, Num 3, pp 1021-1029, issn 0006-4971, 9 p.Article

Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinomaGEIGER, Christiane; NOSSNER, Elfriede; FRANKENBERGER, Bernhard et al.Journal of molecular medicine (Berlin. Print). 2009, Vol 87, Num 6, pp 595-612, issn 0946-2716, 18 p.Article

Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8⁺ T cellsKAUSCHE, Sandra; WEHLER, Thomas; RANIERI, Elena et al.Cancer research (Baltimore). 2006, Vol 66, Num 23, pp 11447-11454, issn 0008-5472, 8 p.Article

BRaf and MEK Inhibitors Differentially Regulate Cell Fate and Microenvironment in Human Hepatocellular CarcinomaBREUNIG, Christian; MUELLER, Bernadett J; UMANSKY, Ludmila et al.Clinical cancer research (Print). 2014, Vol 20, Num 9, pp 2410-2423, issn 1078-0432, 14 p.Article

Correlation of Molecular Human Leukocyte Antigen Typing and Outcome in High-Risk Melanoma Patients Receiving Adjuvant InterferonGOGAS, Helen; KIRKWOOD, John M; FALK, Christine S et al.Cancer. 2010, Vol 116, Num 18, pp 4326-4333, issn 0008-543X, 8 p.Article

Cell-based vaccines for renal cell carcinoma : genetically-engineered tumor cells and monocyte-derived dendritic cellsFRANKENBERGER, Bernhard; REGN, Sybille; SIEBELS, Michael et al.World journal of urology (Print). 2005, Vol 23, Num 3, pp 166-174, issn 0724-4983, 9 p.Article

Membrane receptors are not required to deliver granzyme B during killer cell attackKURSCHUS, Florian C; BRUNO, Roxana; FELLOWS, Edward et al.Blood. 2005, Vol 105, Num 5, pp 2049-2058, issn 0006-4971, 10 p.Article

Natural Killer Cells are Scarce in Colorectal Carcinoma Tissue Despite High Levels of Chemokines and CytokinesHALAMA, Niels; BRAUN, Monika; SCHIRMACHER, Peter et al.Clinical cancer research (Print). 2011, Vol 17, Num 4, pp 678-689, issn 1078-0432, 12 p.Article

Suppression of human CD4+ T cell activation by 3,4-dimethoxycinnamonyl-anthranilic acid (tranilast) is mediated by CXCL9 and CXCL10HERTENSTEIN, Anne; SCHUMACHER, Theresa; LITZENBURGER, Ulrike et al.Biochemical pharmacology. 2011, Vol 82, Num 6, pp 632-641, issn 0006-2952, 10 p.Article

Down-regulation of HLA Class I and NKG2D ligands through a concerted action of MAPK and DNA methyltransferases in colorectal cancer cellsSERS, Christine; KUNER, Ruprecht; STELNIEC, Iwona et al.International journal of cancer (Print). 2009, Vol 125, Num 7, pp 1626-1639, issn 0020-7136, 14 p.Article

Cytotoxic markers and frequency predict functional capacity of natural killer cells infiltrating renal cell carcinomaSCHLEYPEN, Julia S; BAUR, Nicole; FALK, Christine S et al.Clinical cancer research. 2006, Vol 12, Num 3, pp 718-725, issn 1078-0432, 8 p., 1Article

Renal cell carcinoma-infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypesSCHLEYPEN, Julia S; VON GELDERN, Marion; WEISS, Elisabeth H et al.International journal of cancer. 2003, Vol 106, Num 6, pp 905-912, issn 0020-7136, 8 p.Article

Retaliation against tumor cells showing aberrant HLA expression using lymphokine activated killer-derived T cellsFALK, Christine S; NOESSNER, Elfriede; WEISS, Elisabeth H et al.Cancer research (Baltimore). 2002, Vol 62, Num 2, pp 480-487, issn 0008-5472Article